Senior Director Contracting Operations at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Accomplished commercial leader within the pharmaceutical or biopharmaceutical industry, with broad functional expertise across sales, marketing, and market access
Proven track record of leading large, cross-functional teams and driving strategic initiatives
Deep understanding of the external pharmaceutical market, payer dynamics, and evolving reimbursement landscape
Subject matter expertise in the 340B ecosystem, including regulatory trends and operational implications
Exceptional analytical capabilities, systems thinking, and business acumen
Skilled in building and optimizing cross-functional partnerships with Government Affairs, Information Technology, Legal, and Finance/Accounting
Strong decision-making ability, balancing strategic, financial, and operational considerations to achieve optimal outcomes

Responsibilities

Serves as a key member of the senior leadership team for Market Access Operations, reporting directly to the Executive Director
Leads a team of 20+ professionals to drive operational excellence across all U.S. business units in Market Access Contracting and Rebates
Directs the development and execution of optimized 340B operational strategies in collaboration with Government Affairs, Finance, and Commercial Brand teams
Ensures accurate, timely, and compliant reimbursement payments for both Commercial and Government channels, in alignment with contractual and statutory requirements
Champions best-in-class operational support across multiple disciplines and fosters strong cross-functional relationships with key internal stakeholders
Develops and monitors key performance indicators and reporting tools to provide actionable insights into financial and operational drivers
Strategically allocates human and financial resources across business units and franchises to maximize impact and efficiency
Serves as a primary point of contact for external stakeholders, including managed care organizations and government entities, and internal teams such as National Accounts, Accounts Payable, and Accounts Receivable
Provides strategic input into Gross-to-Net (GTN) assumptions, methodologies, and outcomes
Drives team performance by empowering ownership, fostering accountability, and cultivating a high-performance culture
Evaluates and leverages individual and team strengths to optimize organizational effectiveness

Skills

Contracting Operations

Rebates Management

340B Strategy

Team Leadership

Market Access Operations

Operational Excellence

Strategic Planning

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free